Understanding Cancer Treatment: Why There's No Single Cure and Current Therapeutic Options

Why No Universal Cure?

Cancer is not a single disease but hundreds of distinct molecular entities driven by diverse genetic mutations (oncogenes, tumor suppressors, DNA repair genes) and epigenetic alterations, shaped by microenvironment and host immunity. A "magic bullet" for all cancers is biologically implausible.

Current Treatment Modalities

• Surgery: Curative for localized solid tumors; debulking for advanced disease.
• Radiation therapy: DNA damage → cell death; used definitively, adjuvantly, or palliatively.
• Systemic therapy:
  • Cytotoxic chemotherapy: targets rapidly dividing cells.
  • Targeted therapy: inhibits specific molecular drivers (e.g., EGFR, HER2, BCR-ABL, BRAF, ALK).
  • Immunotherapy: checkpoint inhibitors (anti-PD-1/PD-L1, CTLA-4), CAR-T cells, bispecific antibodies.
  • Hormonal therapy: for hormone-receptor-positive breast/prostate cancer.
  • Antibody-drug conjugates: targeted chemotherapy delivery.
• Precision oncology: NGS profiling matches patients to targeted agents or clinical trials.

Treatment Selection

Depends on cancer type, stage, molecular profile, patient comorbidities, preferences, and access. Multidisciplinary tumor boards optimize decisions.

Outlook

While "cure" remains elusive for many metastatic cancers, survival has improved dramatically for many subtypes. The goal is increasingly chronic disease management with quality of life.